Compugen
| Use attributes for filter ! | |
| Stock price | CGEN |
|---|---|
| Disclaimer | |
| Headquarters | Tel Aviv District |
| Israel | |
| Founded | February 10 |
| 1993 | |
| Key people | Paul J Sekhri |
| Anat Cohen-Dayag | |
| Founders | Eli Mintz |
| Simchon Faigler | |
| Amir Natan | |
| Subsidiaries | Evogene |
| Compugen USA, Inc | |
| Neviah Genomics Ltd | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2980739 |
About Compugen
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993.